Medical Developments International

Medical Developments International EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Medical Developments International (MVP.AX) as of Oct 18, 2026 is 47.96. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 16.50 — a change of 190.73% (higher).

EV/EBIT

47.96

YoY

190.73%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Medical Developments International is 2026 47.96 . EV/EBIT (Enterprise Value to EBIT) of Medical Developments International was 2025 16.50 . It decreases by 190.73% higher compared to the previous year.

The Medical Developments International EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
15.98 AUD
Jan 1, 2020
116.54 AUD
Jan 1, 2021
-9.68 AUD
Jan 1, 2022
-3.20 AUD
Jan 1, 2023
-2.48 AUD
Jan 1, 2024
-3.01 AUD
Jan 1, 2025
16.50 AUD
Jan 1, 2026
47.96 AUD
The Medical Developments International EV/EBIT history
YEAREV/EBITYoY
47.96+190.73%
16.50-648.88%
-3.01+21.20%
-2.48-22.46%
-3.20-66.95%
-9.68-108.30%
116.54+629.43%
15.98-86.10%
114.96+693.88%
14.48+1.57%
14.26-17.55%
17.29-41.68%
29.65+61.21%
18.39-35.74%
28.62+76.67%
16.20-30.86%
23.43+100.43%
11.69-6.10%
12.45-19.68%
15.50—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medical Developments International Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Medical Developments International's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Medical Developments International's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Medical Developments International's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Medical Developments International grows earnings faster than its peers.

Medical Developments International Stock analysis

What does Medical Developments International do? Medical Developments International Ltd is an Australian company specializing in the development and production of medical devices and products. The company was founded in 1971 by renowned researcher and entrepreneur Mark Sullivan and has since received numerous awards and accolades. The company's business model is based on the manufacture of emergency medical devices and products of the highest quality and effectiveness. It has three main business segments: Pharmaceuticals, Medical devices, and Animal health. Medical Developments International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medical Developments International stock

EV/EBIT (Enterprise Value to EBIT) of Medical Developments International is 47.96 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Medical Developments International changed from 16.50 to 47.96, representing a 190.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Medical Developments International since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Medical Developments International with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Medical Developments International

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Medical Developments International